Published: September 26, 2008
BASi Appoints New Vice President of Sales & Marketing

BASi (Bioanalytical Systems, Inc.)
(NASDAQ: BASI) has named Jon Brewer as Vice President - Sales and Marketing
effective October 1, 2008. He replaces Emilio Córdova who has resigned from
BASi to pursue other opportunities.
Mr. Brewer has nearly 25 years of experience as a sales and marketing
executive in the pharmaceutical industry. Most recently he consulted with
companies to develop and implement new business strategies. Prior to that
he served as Vice President of Integrity Pharmaceuticals and continued in
this role through the merger with Xanodyne, a specialty pharmaceutical
company headquartered in Cincinnati, Ohio. He has a strong history of
developing and executing product launches and sales strategies resulting in
exceptional sales growth.
As part of his compensation package, the Company has agreed to grant Mr.
Brewer incentive options to purchase 30,000 common shares under its 2008
Employee Incentive Stock Option Plan at the per-share market price at the
close of business on the last trading day prior to the date Mr. Brewer
commences employment with the Company. The option grants are contingent
upon Mr. Brewer commencing employment with the Company.
BASi provides contract research services and unique analytical instruments
to the world's leading drug development companies. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking new drugs to market. Visit www.bioanalytical.com
for more information about BASi.
This release contains forward-looking statements that are subject to risks
and uncertainties including,
but not limited to, risks and uncertainties related to the development of
products and services,
changes in technology, industry standards and regulatory standards, and
various market and
operating risks detailed in the Company's filings with the Securities and
Exchange Commission.
Copyright © 2012, MarketWire
Copyright © 2012, NewsBlaze,
Daily News